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CHAPTER-I 
INTRODUCTION 
Drug delivery systems (DDS) are a strategic tool for expanding 
markets/indications, extending product life cycles and generating opportunities. Oral 
administration is the most popular route for systemic effects due to its ease of ingestion, 
pain, avoidance, versatility and most importantly, patient compliance. Also solid oral 
delivery systems do not require sterile conditions and are therefore, less expensive to 
manufacture. Patient compliance, high-precision dosing, and   manufacturing efficiency 
make tablets the solid dosage form of choice. Excipients and equipments choices will be 
significantly affected should solid dosage form technologies change in response to the 
unprecedented shifts in the drug discovery such as genomics. Should next generation 
drugs are predominantly protein or peptide based, tablets may no longer may be the 
dominant format give the difficulty of dosing such moiety. Injections generally are not 
favored for use by patients unless facilitated by sophisticated auto injectors. Inhalation is 
one good alternative system to deliver these drugs, but the increased research into 
biopharmaceuticals so far has generated predominantly chemical entities with low 
molecular weights. The development of enhanced oral protein delivery technology by 
Fast dissolving Tablets which may release these drugs in the mouth are very promising 
for the delivery of high molecular weight protein and peptide. The oral route remains the 
perfect route for the administration of therapeutic agents because the low cost of therapy, 
manufacturing and ease of administration lead to high levels of patient compliance. Many 
patients have difficulty swallowing tablets and hard gelatin capsules and consequently do 
not take medications as prescribed. It is estimated that50% of the population is affected 
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by this problem, which results in a high incidence of noncompliance and ineffective 
therapy. The demand for solid dosage forms that can be dissolved and suspended in 
water, chewed, or rapidly dissolved in the mouth is particularly strong in the pediatric and 
geriatric markets, with further application to other patients who prefer the convenience of 
a readily administered dosage form. Because of the increase in the average human life 
span and the decline, with age, in swallowing ability, oral tablet administration to patients 
is a significant problem and has become the object of public attention. The problem can 
be resolved by the creation of rapidly dispersing or dissolving oral forms, which do not 
require water to aid swallowing. The dosages forms are placed in the mouth, allowed to 
disperse or dissolve in the saliva, and then are swallowed in the normal way. Less 
frequently, they are designed to be absorbed through the buccal and esophageal mucosa 
as the saliva passes into the stomach. In the latter case, the bioavailability of a drug from 
fast dispersing formulations may be even greater than that observed for standard dosage 
forms. 
The concept of Mouth Dissolving Drug Delivery System emerged from the desire 
to provide patient with more conventional means of taking their medication. It is difficult 
for many patients to swallow tablets and hard gelatin capsules. Hence they do not comply 
with prescription, which results in high incidence of non-compliance and ineffective 
therapy. In some cases such as motion sickness, sudden episodes of allergic attacks or 
coughing and unavailability of water, swallowing conventional tablets may be difficult. 
Particularly the difficulty is experienced by pediatric and geriatric patients. Such 
problems can be resolved by means of Fast Dissolving Tablet. When put on tongue, this 
tablet disintegrates instantaneously, releasing the drug, which dissolves or disperses in 
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the saliva. Some drugs are absorbed from the mouth, pharynx and esophagus as the saliva 
passes down into the stomach. In such cases, bioavailability of drug is significantly 
greater than those observed from conventional tablet dosage form. FDDTs disintegrate 
and/or dissolve rapidly in the saliva without the need for water. Some tablets are designed 
to dissolve in saliva remarkably fast, within a few seconds, and are true fast-dissolving 
tablets. 
Others contain agents to enhance the rate of tablet disintegration in the oral cavity, and 
are more appropriately termed fast-disintegrating tablets, as they may take up to a minute 
to completely disintegrate. When put on tongue, this tablet disintegrates instantaneously, 
releasing the drug, which dissolves or disperses in the saliva. Some drugs are absorbed 
from the mouth, pharynx and esophagus as the saliva passes down into the stomach. In 
such cases, bioavailability of drug is significantly greater than those observed from 
conventional tablet dosage form. FDDTs, as a novel dosage form, have several 
characteristics to distinguish them from the more traditional dosage forms. Taste-masking 
is of critical importance in the formulation of an acceptable FDDT. 
Traditional tablet formulations generally do not address the issue of taste 
masking, because it isassumed that the dosage form will not dissolve until passing the 
oral cavity. Many oral suspensions, syrups and chewable tablets simply contain flavors, 
sugars and other sweeteners to overwhelm or complement the bitter taste of the drug. 
Current methods of taste masking in fast dissolving/ drug particles. FDTs are the 
disintegrating tablets include sweeteners and flavors; however, these are not a sufficient 
means for taste-masking many bitter drugs. Most of the FDDT technologies incorporate 
unique forms of taste masking as well. The primary methods of taste-masking include 
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adsorption onto or complexation with carriers and spray coating of solid dosage forms, 
which increase consumer choice, for the reason of rapid disintegrate/dissolve in oral 
cavity within seconds and swallowed without the need of water or chewing. As tablet 
disintegrates in mouth this could enhance the clinical effect of the drug through pre-
gastric absorption from the mouth, pharynx and esophagus. This leads to an increase in 
bioavailability by avoiding first pass metabolism. 
Fast dissolving drug delivery can be achieved various techniques like direct compression, 
wet granulation, compression moulding, volatization and freeze – drying. They involve 
different mechanisms like use of high amounts of hydrophilic disintegrating agents which 
allow the dosage forms to disintegrate quickly in the patient’s mouth on contact with 
saliva. 
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CHAPTER-II 
FAST DISSOLVING TABLETS - A REVIEW 
DEFINITION 
A fast dissolving tablet can be defined as a solid dosage form that can disintegrates 
into smaller granules which slowly dissolve in the mouth. The disintegration time for fast 
dissolving tablet varies from a few seconds to more than a minute depending on the 
formulation and the size of the tablet.  
A fast disintegrating or dissolving system or tablet can be defined as a solid dosage 
form that can disintegrate or dissolve within 30 seconds, in the oral cavity resulting in a 
solution or suspension without administration of water. The fast disintegrating tablets are 
synonymous with fast dissolving tablets; melt in mouth tablets, rapimelts, Porous tablets, 
Orodispersible, quick dissolving or rapidly disintegrating tablets. 
DIFFICULTIES WITH EXISTING ORAL DOSAGE FORM 
Patient may suffer from tremors therefore they have difficulty to take powder and 
liquids. In dysphasia physical obstacles and adherence to an esophagus may cause 
gastrointestinal ulceration. Swallowing of solid dosage forms like tablet and capsules and 
produce difficulty for young adult of incomplete development of muscular and nervous 
system and elderly patients suffer from dysphasia. Liquid medicaments (suspension and 
emulsion) are packed in multidose container; therefore achievement of uniformity in the 
content of each dose may be difficult. Buccal and sublingual formation may cause irritation 
to oral mucosa, so patients refused to use such medications cost of products is main factor 
as parenteral formulations are most costly and discomfort. 
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SALIENT FEATURES OF MOUTH DISSOLVING DRUG DELIVERY SYSTEM 
DESIRED CRITERIA FOR MOUTH DISSOLVING DRUG DELIVERY SYSTEM 
Mouth Dissolving Tablet should-Not require water to swallow, but it should 
dissolve or disintegrate in the mouth within matter of seconds. Be compatible with taste 
masking Be portable without fragility concern. Have a pleasing mouth feel. Leave minimal 
or no residue in the mouth after oral administration. Exhibit low sensivity to environmental 
condition as humidity and temperature. Be manufactured using conventional processing 
and packaging equipment at low cost. Ease of administration to patients who refuse to 
swallow a tablet, such as pediatric and geriatric patients and psychiatric patients. 
Convenience of administration and accurate dosing as compared to liquids. No need of 
water to swallow the dosage from, which is highly convenient feature for patients who are 
traveling and do not have immediate access to water. Good mouth feel property of MDDS 
helps to change the basic view of medication as “bitter pill”, particularly for pediatric 
patients. Rapid dissolution and absorption of drug, which may produce rapid onset of 
action.  Some drugs are absorbed from the mouth, pharynx and esophagus as the saliva 
passes down into the stomach, and in such cases bioavailability of drugs in increased. 
Ability to provide advantages of liquid medication in the form of solid preparation. 
Pregastric absorption can result in improved bioavailability and as a result of reduced 
dosage, improved clinical performance through a reduction of unwanted effects. 
IDEAL CHARACTERISTICS OF FAST DISSOLVING DELIVERY SYSTEM 
Mouth-feel - Mouth-feel is critical, and patients should receive a product that feels 
pleasant. Any large particles from the disintegrating tablet that are insoluble or slowly 
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soluble in saliva would lead to an unpleasant gritty feeling. This can be overcome by 
keeping the majority of the particles below the detectable size limit. In some cases, certain 
flavors can an improved mouth-feel perception, resulting in a product that is perceived as 
being less gritty, even if the only change is the flavor. Effervescence can be added to aid 
disintegration and improve mouth-feel by reducing the “dryness” of a product. 
Hygroscopicity - Several fast dissolving dosage forms are hygroscopic and cannot maintain 
physical integrity under normal conditions of temperature and humidity. Hence they need 
protection from humidity, which calls for specialized product packaging. Friability - In 
order to allow fast dissolving tablets to dissolve in the mouth, they are made of either very 
porous or soft molded matrices or compressed into tablets with very low compression 
force, which makes the tablets friable and/or brittle which are difficult to handle, often 
requiring specialized peel off blister packing. To overcome this problem, some companies 
introduced more robust forms of fast dissolving tablets, such as Wowtab by Yamanouchi-
Shadlee and Dura Solve by CIMA labs. 
 Excipients balance the properties of the actives in fast-melting tablets. This 
demands a thorough understanding of the chemistry of these excipients to prevent 
interaction with the actives. Determining the cost of these ingredients is another issue that 
needs to be addressed by formulators. The role of excipients is important in the formulation 
of fast-melting tablets. These inactive food-grade ingredients, when incorporated in the 
formulation, impart the desired organoleptic properties and product efficacy. Excipients are 
general and can be used for a broad range of actives, except some actives that require 
masking agents. 
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BULKING MATERIALS: 
 Bulking materials are significant in the formulation of fast-melting tablets. The 
material contributes functions of a diluent, filler and cost reducer. Bulking agents improve 
the textural characteristics that in turn enhance the disintegration in the mouth, besides; 
adding bulk also reduces the concentration of the active in the composition. The 
recommended bulking agents for this delivery system should be more sugar-based such as 
mannitol, polydextrose, lactitol, DCL (direct compressible lactose) and starch hydrolystate 
for higher aqueous solubility and good sensory perception. Mannitol in particular has high 
aqueous solubility and good sensory perception. Bulking agents are added in the range of 
10 percent to about 90 percent by weight of the final composition. 
EMULSIFYING AGENTS: 
 Emulsifying agents are important excipients for formulating fast-melting tablets 
they aid in rapid disintegration and drug release without chewing, swallowing or drinking 
water. In addition, incorporating emulsifying agents is useful in stabilizing the immiscible 
blends and enhancing bioavailability. A wide range of emulsifiers is recommended for fast-
tablet formulation, including alkyl sulfates, propylene glycol esters, lecithin, sucrose esters 
and others. These agents can be incorporated in the range of 0.05 percent to about 15 
percent by weight of the final composition. 
LUBRICANTS: 
 Lubricants, though not essential excipirnts, can further assist in making these tablets 
more palatable after they disintegrate in the mouth. Lubricants remove grittiness and assist 
in the drug transport mechanism from the mouth down into the stomach. 
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FLAVOURS AND SWEETENERS: 
 Flavours and taste-masking agents make the products more palatable and pleasing 
for patients. The addition of these ingredients assists in overcoming bitterness and 
undesirable tastes of some active ingredients. Both natural and synthetic flavours can be 
used to improve the organoleptic characteristic of fast-melting tablets. Formulators can 
choose from a wide range of sweeteners including sugar, dextrose and fructose, as well as 
non-nutritive sweeteners such as aspartame, 
sodium saccharin, sugar alcohols and sucralose. The addition of sweeteners contributes a 
pleasant taste as well as bulk to the composition. 
SUPER DISINTEGRANTS: 
 A disintegrant is an excipient, which is added to a tablet or capsule blend to aid in 
the breakup of the compacted mass when it is put into a fluid environment. 
ADVANTAGES: 
 Effective in lower concentrations Less effect on compressibility and flowability 
More effective intragranularly 
Some super disintegrants are: 
1) Sodium Starch Glycolate (Explotab, primogel) used in concentration of 2-8 % & 
optimum is 4%. 
 Mechanism of Action: Rapid and extensive swelling with minimal gelling. 
Microcrystalline cellulose (Synonym: Avicel, celex) used in concentration of 2-15% of 
tablet weight. And Water wicking 
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2) Cross-linked Povidone (crospovidone) (Kollidone) used in concentration of 2-5% of 
weight of tablet. Completely insoluble in water. 
Mechanism of Action: Water wicking, swelling and possibly some deformation recovery. 
Rapidly disperses and swells in water, but does not gel even after prolonged exposure. 
Greatest rate of swelling compared to other disintegrants. Greater surface area to volume 
ratio than other disintegrants. 
3) Low-substituted hydroxyl propyl cellulose, which is insoluble in water. Rapidly 
swells in water. Grades LH-11 and LH-21 exhibit the greatest degree of swelling. Certain 
grades can also provide some binding properties while retaining disintegration capacity. 
Recommended concentration 1-5% 
4) Cross linked carboxy methyl cellulose sodium (i.e. Ac-Di-sol) Croscarmellose 
sodium: 
Mechanism of Action: Wicking due to fibrous structure, swelling with minimal gelling. 
Effective Concentrations: 1-3% Direct Compression, 2-4% Wet Granulation 
Gas producing disintegrants 
 Gas producing disintegrants are used especially where extra rapid disintegration or 
readily soluble formulation is required. They have also been found of value when poor 
disintegration characteristics have resisted other methods of improvement. Care should be 
taken during tab letting, particularly on moisture level. Composition is based upon the 
same principles as those used for effervescent tablets, the most common being mixtures of 
citric & tartaric acids plus carbonates or bicarbonates. In many instances lower 
concentration can be used with gas producing disintegrants than are required by other 
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disintegrating agents. Certain peroxides that release oxygen have been tried, but they do 
not perform as well as those releasing carbon dioxide. 
 
 
Conventional Technique Used In The Preparation Of MFDTS. 
 Freeze drying technique 
 Tablet molding technique 
 Spray drying technique 
 Direct compression technique 
 Sublimation technique 
 Mass extrusion technique 
Freeze Drying Technology (Zydis Technology)  
 Lyophilization can be used to prepare tablets that have very porous open matrix 
network into which saliva rapidly moves to disintegrate lyophilized mass after it is placed 
in mouth. 
The drug is entrapped in a water soluble matrix whichis freeze dried to produce a unit 
which rapidly disperses when placed in mouth. Apart from the matrix and active  
constituents, the final formulation may contain other excipients, which improve the process 
characteristics or enhance the quality of final product. These include suspending agents, 
wetting agents, preservatives, antioxidants, colors and flavors. The preferred drug 
characteristics for freeze drying formulations are water insoluble, low dose, chemically 
stable, small particle size and tasteless. Corveleyn and Remon investigated the influence of 
various formulation and process parameters on the characteristics of rapidly disintegrating 
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tablets in lyophilized form using hydrochlorthiazide as a model drug. They have concluded 
that maltodxtrins are useful in the formulation of fast dissolving tablets made by freeze-
drying. Lyophilization is relatively expensive and time consuming manufacturing process. 
Other drawback includes fragility, which make the use of conventional packing difficult 
and poor stability during storage under stressful condition. 
Tablet Molding  
 In this technology, water-soluble ingredients are used so that tablet disintegrate and 
dissolve rapidly. The powder blend is moistened with a hydro alcoholic solvent and is 
molded in to tablet using compression pressure lower than used in conventional tablets 
compression. The solvent is then removed by air-drying. Molded tablets have a porous 
structure that enhances dissolution. Two problems commonly encountered are mechanical 
strength and poor taste masking characteristics. Using binding agents such as sucrose, 
acacia or poly vinyl pyrrolidone can increase the mechanical strength of the tablet. To 
overcome poor taste masking characteristic Van Scoik incorporated drug containing 
discrete particles, which were formed by spray congealing a molten mixture of 
hydrogenated cottonseed oil, sodium bicarbonate, lecithin, polyethylene glycol and active 
ingredient into a lactose based tablet triturate form. 
Spray Drying  
 Spray dryers are widely used in pharmaceuticals and biochemical processes. Due to 
processing solvent is evaporated rapidly; spray drying can produce highly porous, fine 
powder. Spray drying can be used to prepare rapidly disintegrating tablets. This technique 
is based on a particulate support matrix, which isprepared by spray drying an aqueous 
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composition containing support matrix and other components to form a highly porous and 
fine powder. This is then mixed with active ingredients and compressed into tablets. 
 
 
Direct Compression Method  
 In this method, tablets are compressed directly from the mixture of the drug and 
excipients without any preliminary treatment. The mixture to be compressed must have 
adequate flow properties and cohere under pressure thus making pretreatment as wet 
granulation unnecessary. Few drugs can be directly compressed into tablets of acceptable 
quality. A type of disintegrant and its proportion are of prime importance. The other factors 
to be considered are particle size distribution, contact angle, pore size distribution, tablet 
hardness and water absorption capacity. All these factors determine the disintegration. The 
disintegrant addition technology is cost effective and easy to implement at industrial level. 
Sublimation Technique 
 The basis of this technique is to add inert solid ingredients that volatilize readily, 
(e.g. camphor, ammonium bicarbonate, naphthalene, urea, urethane etc) to other tablet 
excipients and the mixture is then compressed into tablets. Volatile material is then 
removed via sublimation, which generate a porous structure. 
Mass-Extrusion (Mass-Extrusion)  
  This technology involves softening the active blend using the solvent 
mixture of water-soluble polyethylene glycol and methanol and subsequent expulsion of 
softened mass through the extruder or syringe to get a cylinder of the product into even 
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segments using heated blade to form tablets. The dried cylinder can also be used to coat 
granules for bitter drugs and thereby achieve taste masking 
PATENTED TECHNOLOGIES OF FDTs [20] 
 
Currently, four fast-dissolving/disintegrating technologies have reached the U.S. market: 
 
 Zydis (R.P. Scherer, Inc.) 
, 
 WOWTAB (Yamanouchi Pharma Technologies, Inc.) 
 , 
 OraSolv (Cima Labs, Inc.). 
 
 DuraSolv (Cima Labs, Inc.). 
 
 Three others are available outside the U.S. : 
 
 FlashDose (Fuisz Technologies, Ltd.), 
 
 Flashtab (Prographarm Group), 
 
 OraQuick (KV Pharmaceutical Co., Inc.). 
Zydis Technology  
 Zydis formulation is a unique freeze dried tablet in which drug is physically 
entrapped or dissolved within the matrix of fast-dissolving carrier material. When zydis 
units are put into the mouth, the freeze-dried structure disintegrates instantaneously and 
does not require water to aid swallowing. The zydis matrix is composed of many materials 
designed to achieve a number of objectives. To impart strength and resilience during 
handling, polymers such as gelatin, dextran or alginates are incorporated. These forms a 
glossy amorphous structure, which imparts strength. To obtain crystallinity, elegance and 
hardness, saccharides such as mannitol or sorbitol are incorporated. Water is used in the 
manufacturing process to ensure production of porous units to achieve rapid disintegration. 
Various gums are used to prevent sedimentation of dispersed drug particles in the 
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manufacturing process. Collapse protectants such as glycine prevent the shrinkage of zydis 
units during freeze drying process or long term storage. Zydis products are packed in 
blister packs to protect the formulation from moisture in the environment.  
 
 
 
Limitations 
 The amount of drug could be incorporated should generally be less than 
400mg for insoluble drugs and less that 60mg for soluble drugs. 
 The particle size of the insoluble drugs should not be less than 50µm and not 
more than 200µm to prevent sedimentation during processing. 
Advantages 
 Buccal pharyngeal and gastric regions are all areas of absorption from this 
formulation. Any pre-gastric absorption avoids first-pass metabolism and 
can be an advantage in drugs that undergo a great deal of hepatic 
metabolism. 
 The zydis formulation self-preserving because the final water concentration 
in the freeze-dried product is too low to allow for microbial growth. 
Disadvantages 
 The process of freeze-drying is a relatively expensive manufacturing 
process. 
 The formulation is very lightweight and fragile, and therefore should not be 
stored in backpacks or the bottom of purses. 
 It has poor stability at higher temperatures and humidities. 
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 The freeze-drying is time consuming process 
 It has poor physical resistance 
 Loading of high dose of water-soluble drugs is not possible 
Durasolv Technology  
 Durasolv is the patented technology of CIMA labs. The tablets made by this 
technology consist of a drug, fillers and a lubricant. Tablets are prepared by using 
conventional tableting equipment and have good rigidity. These can be packaged into 
conventional packaging system like blisters. Durasolv is an appropriate technology for 
products requiring low amounts of active ingredients.  
Advantages 
 Durasolv has much higher mechanical strength than its predecessor due to the 
use of higher compaction pressures during tabletting. 
 The Durasolv product is thus produced in a faster and in more effective 
manner. 
Disadvantages 
 It is not compatible with larger doses of active ingredients because the 
formulation is subjected to high pressures on compaction. 
 The drug powder coating may fractured during compaction, exposing the 
bitter tasting drug to patient’s taste buds. 
Orasolv Technology  
 Orasolv Technology has been developed by CIMA labs. In this system active 
medicament is taste masked. It also contains effervescent disintegrating agent. Tablets are 
made by direct compression technique at low compression force in order to minimize oral 
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dissolution time. Conventional blenders and tablet machine is used to produce the tablets. 
The tablets produced are soft and friable and packaged in specially designed pick and place 
system. 
Advantages 
 The Orosolv formulations are not very hygroscopic 
 The formulation can accommodate high doses. 
 It also provides a distinct, pleasant sensation of effervescence in the mouth.  
 
Disadvantages 
 A weaker and more brittle tablet in comparison with conventional tablets. 
 Poor mechanical strength. 
 The cost of fast dissolving tablets is higher than the cost of standard tablets 
made by direct compression 
 Manufacturing requires a controlled environment at low relative humidity. 
Wowtab Technology  
 Wowtab Technology is patented by Yamanouchi Pharmaceutical Co. WOW means 
"Without Water ". In this process, combination of low mouldability saccharides and high 
mouldability saccharides is used to obtain a rapidly melting strong tablet. The active 
ingredient is mixed with a low mouldability saccharide and granulated with a high 
mouldability saccharide and compressed into tablet. 
Advantages 
 Offers Superior mouthfeel due to the smooth melt action  
 It is suitable for both conventional bottle and blister packaging 
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 Bit more stable to the environment than the zydis and orasolv. 
Flash Dose Technology  
 Flash dose technology has been patented by Fuisz. Nurofen meltlet, a new form of 
ibuprofen as melt-in-mouth tablets, prepared using flash dose technology is the first 
commercial product launched by Biovail Corporation. Flash dose tablets consists of self-
binding shearform matrix termed as "floss". Shearform matrices are prepared by flash heat 
processing.  
Flashtab Technology  
 Prographarm laboratories have patented the Flashtab technology. Tablets prepared 
by this system consist of an active ingredient in the form of microcrystals. Drug 
microgranules may be prepared by using the conventional techniques like coacervation,  
microencapsulation, and extrusion- spheronisation. All the processing utilized conventional 
tabletting technology. 
 
Oraquick Technology  
 The Oraquick fast dissolving/disintegrating tablet formulation utilizes a patented 
taste masking technology. KV Pharmaceutical claims its micro sphere technology, known 
as Micro Mask, has superior mouth feel over taste-masking alternatives. The taste masking 
process does not utilize solvents of any kind, and therefore leads to faster and more 
efficient production. Also, lower heat of production than alternative fast-
dissolving/disintegrating technologies makes Oraquick appropriate for heat-sensitive drugs. 
KV Pharmaceutical also claims that the matrix that surrounds and protects the drug powder 
in microencapsulated particles is more pliable, meaning tablets can be compressed to 
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achieve significant mechanical strength without disrupting taste-masking Oraquick claims 
quick dissolution in a matter of seconds, with good taste-masking. There are no products 
using the Oraquick technology currently on the market, but KV pharmaceutical has 
products in development such as analgesics, scheduled drugs, cough and cold,  
psychotropics, and anti-infectives. 
Each technology has a different mechanism, and each fast-dissolving/disintegrating dosage 
form varies regarding the following:  
 Mechanical strength of final product; 
 Drug and dosage form stability; 
 Mouth feel; 
 Taste; 
 Rate of dissolution of drug formulation in saliva; 
 Swallow ability; 
 Rate of absorption from the saliva solution; and 
 Overall bioavailability. 
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CHAPTER-III 
LITERATURE REVIEW 
Viral Shah et al., 2011, Formulation and Evaluation of Mouth Dissolving Tablets of 
Metaclopramide Hcl by Direct compression technique. The tablets were prepared by direct 
compressed method using crospovidone, croscarmallose sodium and sodium starch glycolate 
and superdisintegrant. Tablets containing crospovidone showed better disintegration 
character along with rapid release. 
Vineet Bhardwaj et al., 2010, Formulation and Evaluation of Fast Dissolving Tablet of 
Amlodopine besylate using different superdisintegrants and camphor as sublimating agent. 
The tablets were prepared by direct compression method. Different concentrations (2% 4% 
5% 6%) of super disintegrants such as Ac-Di-sol, Sodium starch glycolate, kollidon-CL were 
used as superdisintegrant, camphor was used as sublimating agent. The result concluded that 
the formulation containing 6% croscarmallose sodium has greater release rate and faster 
disintegration time than other formulations.  
Vikram Chopra et al., 2009, Formulation, Evaluation and Comparison of Fast Dissolving 
Tablet of Nimesulide by using Crospovidone as superdisintegrant. Fast dissolving tablets of 
nimesulide were prepared by using crospovidone as 
superdisintegrant (crospovidone) was used in different concentration to formulate fast 
dissolving tablets of nimesulide and optimized batch was compared with marketed 
formulation. It can be concluded in the research study that the disintegration of nimesulide 
can be enhanced by direct compression technique with addition of crospovidone. 
Vijay Tiwari et al., 2010, Preparation and Evaluation of Fast Dissolving Tablets of 
Celecoxib. Fast dissolving dosage from proves its significance for enhancing the 
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bioavailability of water insoluble drug by increasing its dissolution and solubility. The 
inclusion of solid dispersion process as a step of preparation of fast dissolving tablets have a 
synergistic effect on bioavailability of final dosage form by its contribution in improvement 
of solubility profile. It proves that the concentration of superdisintegrants plays a major role 
in release profile of fast dissolving tablets. 
Uday S Rangole et al., 2008, Formulation and In Vitro Evaluation of rapidly disintegrating 
tablets using Hydrochlorthiazide as model drug. The tablets were prepared by direct 
compression method using 2%, 3%, 4%, 5% of superdisintegrants like croscarmallose sodium 
and crospovidone. The tablets containing 4% crospovidone  gave fast disintegration  and  
highest dissolution rates. 
Suhas M. Kakade et al., 2010, Formulation and Evaluation of Mouth Dissolving Tablets of 
Losartan potassium by Direct Compression Method. The mouth dissolving tablets were 
prepared by direct compression method using disintegrants like ployplasdone XL 10, 
croscarmallose sodium and explotab in different concentrations. The relative efficacy of 
different superdisintegrants to improve dissolution rate of tablets is in the order of 
ployplasdoneXL 10 > croscarmallose sodium > Explotab. 
Sridhar B.K. et al., 2010, Formulation and Evaluation of Fast dissolving / Disintegrating 
tablets of Isoxsuprine Hcl. The tablets were prepared by direct compression method using 
crospovidone, croscarmallose sodium and sodium starch glycolate as superdisintegrants at 
various levels. The formulation containing 5% croscarmallose sodium showed complete 
release of drug within 4 minutes than other formulations.  
 Shirshand S.B. et al., 2010, Formulation design and Optimization of Fast Disintegranting 
Lorazepam Tablets by Effervescent Method”. The tablets were prepared by effervescent 
method with a view to enhance patient compliance. A 3
2
 full factorial design was applied to 
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investigate the combined effect of two formulation variables: amount of crospovidone and 
mixture of sodium- bi- carbonate, citric acid and tartaric acid on in vitro dispersion time. 
Crospovidone 2 to 8% w/w was used as superdisintegrant and mixture of sodium- bi- 
carbonate, citric acid and tartaric acid (6 to 18% w/w) was used as effervescent material 
along with directly compressible mannitol. The formulation containing 8% w/w of 
Crospovidone 18% w/w mixture of sodium- bi- carbonate,  citric acid and tartaric acid was 
found to be promising. 
Sharma vijay et al., 2011, Formulation and Evaluation of  Mouth Dissolving Tablets of 
Cefixime. The tablets were prepared using different concentrations of disintegrants by direct 
compression method. crospovidone, croscarmallose and sodium starch glycolate and Kyron 
T-314 were the superdisintegrants used. The formulation containing 7.5% of crospovidone 
was concluded as best formulation based on wetting time, disintegration time and dissolution 
data. 
Shailendra Kumar singh et al., 2009, Fast Distintegrating Combination Tablets of 
Omeprazole and Domperidone. The tablets were prepared using mannitol as diluent and 
sodium saccharin as sweetening agent along with three different levels of disintegrant. 
Kollidon- Cl, Ac-Di-sol , and sodium starch glycolate  are  the  
superdisintegrants  used. The formulation containing Ac-Di-sol (CCS) 10 mg disintegrated 
fast. 
Senthilnathan B. et al., 2011, Formulation devolepment of Venlafaxine Hcl Orodispersible 
Tablet. The tablets were prepared by direct compression method using crospovidone, 
croscarmallose sodium and sodium starch glycolate as superdisintegrants. Formulation 
containing 10% crospovidone was found to demonstrate desirable properties and optimized 
drug release.      
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Sandhya Jaiswal et al., 2011, Formulation and Evaluation of Mouth Dissolving Tablets of 
Atenolol. The tablets were prepared by direct compression method using crospovidone, 
croscarmallose and sodium starch glycolate in different ratio with directly compressible 
mannitol. The formulation containing 4% w/w of crospovidone emerged as over all best 
formulation with good disintegration time and highest release rate profile than other 
formulations.  
Sachin B.S Mahamuni et al., 2009, Formulation and Evaluation of Fast Dissolving Tablets 
of promethazine Hcl Masked Bitter Taste. Taste masked granules were prepared by extrusion 
method using Eudragit E-100. Fast Dissolving Tablets were prepared by direct compression 
using crospovidone, croscarmallose sodium and sodium starch glycolate as 
superdisintregrants a mixture of excipients containing optimized level of microcrystalline 
cellulose and starch. Tablets containing 5% crospovidone showed the  highest improvement 
in disintegration and dissolution rate. It was concluded that compelxation of promethazine 
Hcl with Eudragit E- 100 masks its bitter taste as well as improved its dissolution profile. 
Ravi Kumar et al., 2009, Formulation and Evaluation of Mouth Dissolving Tablets of 
Fenofibrate using sublimation technique. The mouth dissolving tablets of fenofibrate were 
prepared by sublimation technique using menthol, camphor, ammonium bicarbonate and 
thymol as sublimating agent. The wetting time was observed to be very fast. The total drug 
from optimized batch was found to be released within first ten minutes of dissolutions study. 
The prepared tablets were found to provide  benefits in terms of patient compliance, low 
dosing, rapid onset of action, increased bioavailability, low side effect and good stability. 
Rampure. M.V. et al., 2010, Formulation and Evaluation of Orodispersible Tablets of 
Alfuzosin. The tablets were prepared by sublimation method using camphor as sublimating 
agent along with varying concentrations of croscarmallose sodium, crospovidone, sodium 
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starch glycolate in 2 to 10% w/w.  The formulation containing 10% w/w of crospovidone and 
30% w/w of camphor emerged as overall best formulation based on drug release 
characteristics. 
Rampure M.V. et al., 2011, Formulation and design of Rapidly Disintegrating 
Phenobarbitone Tablets by direct compression method. The formulation containing 8% w/w 
of crospovidone and 15% w/w of microcrystalline cellulose emerged as overall best 
formulations based on in vitro dispersion time and drug release compared to conventional 
commercial tablet.  
Raghavendra Rao N.G. et al., 2009, Formulation and  Evaluation of  Fast Dissolving 
Chlorthalidone Tablets.The fast dissolving chlorthalidone tablets were prepared by direct 
compression using co-grinding and solid dispersion methods by using chlorthalidone.The 
tablet formulation containing Poly vinyl pyrrolidone - 12 solid dispersion showed maximum 
drug release than Poly vinyl pyrrolidone -12 by  
co-grinding method. Results concluded that using solid dispersion of the drug with the 
hydrophilic carrier Poly vinyl pyrrolidone can enhance the dissolution rate of chlorthalidone 
tablets.  
 Raghavendra Rao N.G et al., 2010, Formulation and design of Fast Dissolving Tablets of 
felodipine using novel coprocessed superdisintegrants. The novel co-processed 
superdisintegrants were developed by solvent evaporation method using crospovidone and 
sodium starch glycolate in different ratios (1:1, 1:2, and 1:3) for use in fast dissolving tablets. 
The fast dissolving tablets were prepared by direct compression in method. The results 
concluded that formulation containing (1:1 mixture of crospovidone and sodium starch 
glycolate) has best drug release and dispersion time than other formulations.  
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 Padmavathi Y. et al., 2011, Development of Fixed Dose Combination Dispersible Tablets 
containing Stavudine, Lamivudine and Nevirapine for pediatric applications. Dispersible 
tablets were prepared by direct compression method and formulated using different 
superdisntegrants like croscarmallose sodium, crospovidone, sodium starch glycolate at 
different concentration levels. The effect of superdisintegrant on dispersion time, drug 
content and invitro release has been studied. The formulation containing croscarmallose 
sodium showed good drug release of all the three drugs when compared to formulation 
containing sodium starch glycolate and crospovidone. 
Neena Bedi et al., 2009, Formulation and Evaluation of  Mouth Dissolving Tablets of 
Oxcarbazepine. The mouth dissolving tablets were prepared by two different technologies, 
direct compression method and solid dispersion technique. Tablets produced by direct 
compression method containing crospovione as a superdisintegrant and aspartame as 
sweetener. Solid dispersions of oxcarbazepine with poly vinyl pyrrolidone K-30 and 
polyethylene glycol 6000 in different weight ratio. Solid dispersion with polyvinyl 
pyrrolidone K30 in 1:2 ratios of drug carrier showed maximum drug release. It was 
concluded that solid dispersion technology can be used as better alternative to the direct 
compression method for the formulation of mouth dissolving tablets especially for drugs 
having  poor solubility. 
Narayanan  et al., 2011, Formulation and Evaluation of Olanzapine as Orodispersible Drug 
Delivery System by using β-cyclodextrin and superdisintegrants are used to enhance the 
solubility of drug. The drug is complexed with polymer and tablets are formed in direct 
compression in method. The superdisintegrants crospovidone, croscarmallose sodium, 
sodium starch glycolate are used for formulation in 2 to 5% concentration. The orodispersible 
tablet prepared by using croscarmallose sodium (AC-Di-Sol) as superdisintegrant showed 
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faster relase of drug than both control formulation and formulations prepared with other super 
superdisintegrants. 
Nagendra Kumar D. et al., 2010, Formulation design of Fast Dissolving Tablets of 
Fexofenadine Hcl by sublimation method. Fast dissolving tablets of fexofenadine were 
prepared by sublimation method using camphor as sublimating agent. Crospovidone and 
croscarmallose sodium were used as superdisintegrants. The study concludes that formulation 
containing 8% w/w crospovidone and 30% w/w camphor as best formulation based on 
release characteristics and  invitro dispersion time. 
Margret Chandira M. et al., 2010 “Formulation and Evaluation of Mouth Dissolving 
Tablets of Etoricoxib. The mouth dissolving tablets of etoricoxib were prepared by direct 
compression method using primogel, kollidone, Ac–Di-sol, L-hydroxypropyl 
methylcellulose, L-hydorxypropylcellulose as superdisintegrants in different concentration 
like 4% to8%.The results conclude that formulation containing 8%  L-
hydorxypropylcellulose  showed minimum disintegration time, wetting time and drug 
release.The results showed that disintegration time increased in the manner of L-
hydorxypropylcellulose < kollidone < Ac– Di-sol < primogel < L-hydroxypropyl 
methylcellulose. 
Khole et al., 2011, Development and Evaluation of Melt in Mouth Tablets by Sublimation 
Technique. Solid dispersion of the drug Rizatriptan benzoate and taste masking β-
Cycodextrins prepared. Tablets were formulated by direct compression. The tablets prepared 
using sublimating agents were porous in nature and showed faster disintegration and 
dissolution which is the major aim. 
Kawtikwar. P.S. et al., 2009, Formulation and Optimization of Fast Dissolving Tablet 
containing Tizanidine Hcl. Eudragit E- 100 is used as a taste masking agent. The granules 
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were prepared by mass extrusion technique. There superdisintegrants sodium starch 
glycolate, croscarmallose sodium and crospovidone were used. It was concluded that fast 
dissolving tablets of Tizanidine Hcl can be successfully prepared by superdisintegrants 
addition and sublimation method and superdisintegrant method was found to be superior to 
that of sublimation method. 
Jain C.P. et al., 2009, Formulation and Evaluation of Fast Dissolving Tablets of valsartan. 
The fast dissolving tablets of valsartan were prepared using different superdisintegrants by 
direct compression method. It was concluded that the fast dissolving tablets of valsartan 
containing crospovidone is most acceptable. 
Indhumathi D. et al., 2011, Formulation and Evaluation of Orodispersible tablet of 
Fluoxetine using super disintegrants. The tablets were prepared by wet granulation method 
using crospovidone, pregelatinized starch, croscarmallose sodium and sodium starch 
glycolate as superdisintegrants. It was found and concluded that crospovidone at a 
concentration of 5% w/w showed maximum in vitro dissolution profile and hence it emerged 
as overall best formulation the in vitro drug release of superdisintegrants was in the order of 
crospovidone > pregelatinized starch ˃ croscarmallose sodium > sodium starch glycolate . 
Harish Chander et al., 2011, Formulation and Evaluation of Fast Dissolving Tablets of 
Ramipril. The fast dissolving tablets were prepared by direct compression technique 
(effervescent) with sodium bicarbonate, mannitol, and polyvinyl pyrrolidone. Citric acid in 
different ratios of sodium bicarbonate: Mannitol. In conclusion, overall results suggests that 
fast dissolving tablets the  containing sodium bicarboinate and mannitol in ratio of 1:3 
showed best result in terms of percentage drug release, compressibility index, hardness and 
disintegration time. 
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Gupta S.C et al., 2011, Formulation and Evaluation of Mouth Dissolving Tablets of 
Dicyclomine Hcl with enhanced bioavailability.The mouth dissolving tablets were prepared 
by direct compression method using D-mannitol as diluents, crospovidone as a 
superdisintegrants and aspartame as a sweetener. It was concluded that the formulation 
containing crospovidone as the best formulation with rapid disintegration time and higher 
release rate than other formulations.  
Gohil et al., 2011, Formulation and Characterization of Bambuterol Hcl Fast Dissolving 
Tablet using various superdisintegrants. The tablets were prepared with four disintegrants 
sodium starch glycolate, crospovidone, croscarmallose sodium   
and pregelatinized starch by direct compression method. The maximum increase in 
dissolutions rate was observed with 12% crospovidone amongst the superdisintegrants. The 
order of enhancement of dissolution rate with various disintegrants was found to be 
crospovidone > croscarmallose sodium > sodium starch glycolate > pregelatinized starch. 
Gnanaprakash K. et al., 2009, Formulation and Evaluation of Fast Dissolving Tablets of 
Valdecoxcib. The fast dissolving tablets of valdecoxib were prepared with some carriers 
(polymers) and superdisintegrants such as polyvinyl pyrrolidone (PVP), sodium carboxy 
methyl cellulose; crospovidone and β-cyclodextrin in different proportions of 5%, 10% and 
15% by direct compression method. The formulation containing 15% crospovidone prepared 
using mannitol and aspartame were found to have maximum release at the end of 10 minutes. 
Ganesh Kumar Gudas et al., 2010, Formulation and Evaluation of Fast Dissolving Tablets 
of Chlorpromazine Hcl. The tablets were prepared with five superdisintegrants namely 
sodium starch glycolate, croscarmallose sodium and crospovidone, L-hydroxypropylcellulose 
and pregelatinized starch. The tablets were prepared by direct impression method. The 
maximum increase in dissolution rate was observed with 5% crospovidone amongst the super 
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disintegrants. The order of enhancement of dissolution rate is crospovidone > croscarmallose 
sodium > sodium starch glycolate > L- hydroxypropylcellulose > pregelatinized starch. 
 Diensh Mohan S. et al., 2010, Formulation and Evaluation of Salbutamol Sulphate Fast 
Dissolving Tablet. The tablets were prepared by direct compression method using 
superdisintegrants such as primojel, kollidon CL, L- Hydroxypropylcellulose. The 
effectiveness of super disintegrants was found to be in the order of kollidon CL > Primojel > 
L-Hydroxy propyl cellulose. 
Deshpande K.B. et al., 2011, Formulation and Evaluation of Orodispersible Tablets of 
Propranolol Hcl. The main objective of the present work is to develop orodispersible tablets 
of propranolol Hcl to improve bioavailability, disintegration time, dissolution efficiency and 
patient compliance. The formulation containing 4% crospovidone is considered as the best 
formulation in all parameters. 
Debijit Bhowmik et al., 2009, Design and characterisation of Fast Dissolving Tablets of 
Telmisartan. The tablets were prepared by direct compression method using crospovidone, 
croscarmallose sodium and sodium starch glycolate as superdisintegrants at different levels 
(5%, 7.5% and 10%). The formulation containing 10% crospovidone was found to be 
promising than other formulations with minimum disintegration time and maximum 
dissolution rate. 
Chandrasekar patro et al., 2011, Formulation and Evaluation of Cetrizine Hcl Mouth Fast 
Dissolving Tablets. The tablets were prepared by direct compression methods using 
crospovidone, croscarmallose and sodium starch glycolate in different concentration as 
superdisintegrants. The results indicate that formulation containing 5% croscarmallose 
sodium was found to be optimized with maximum drug release and minimum disintegration 
time.  
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 Chandira. M et al., 2011, Formulation and Evaluation of Fast Dissolving Tablets of 
Rupatidine fumarate. The fast dissolving tablets of rupatidine fumarate were prepared by 
direct compression method using mannitol, microcrystalline cellulose as filler croscarmallose 
sodium, crospovidone, sodium starch glycolate as superdisintegrants at different 
concentrations (2-5%). In conclusion with increase in concentration of superdisintegrant, the 
disintegration time decreases in order of croscarmallose sodium > crospovidone > sodium 
starch glycolate. 
Basawarj S.  patil et al., 2011, Formulation and Evaluation of Granisetron Hcl by Direct 
Compression  Method. The Fast Dissolving Tablets of granisetron Hcl were prepared by 
direct compression method. Effect of super disintegrates (such as crospovidone, 
croscarmallose sodium and sodium starch glycolate) on wetting time, dispersion time, and 
stability parameters were studied.The formulation containing crospovidone as superdistegrant 
showed highest dissolution rate. 
Basawaraj S. patil et al., 2011, Formulation and Evaluation of Fast Dissolving Candesartan 
Cilexetil Tablets. The fast dissolving tablets were prepared by direct compression method 
using croscarmallose sodium and crospovidone as disintegrants. The effect of 
superdisintegrants on wetting time, in vitro dispersion time and stability parameter has been 
studied. The present work revealed that the superdisintegrant crospovidone showed better 
disintegrating and dissolution property than sodium starch glycolate in formulation of  fast 
dissolving tablets . 
Aravind K. Singh et al., 2010, Development and Evaluations of Fast Disintegrating Tablets 
of Salbutamol sulphate by superdisintegranting agents. The fast dissolving tablet is 
formulated using Ac-di-sol, polyplasdone and primogel as super disintegrants. While 
microcrystalline cellulose and mannitol were used as diluents. Direct compression is the 
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technique used. It was concluded that  with  increase in concentration of superdisintegrants, 
the disintegration time decreases in Ac- Di-sol and poly plasdone XL, while increases in 
primogel due to formation of viscous plug on swelling. 
Althaf et al., 2011, Formulation and Evaluation of Oral Fast Dissolving Tablets of Sildenafil 
Citrate. The Mouth Dissolving Tablets were prepared by wet granulation and direct 
compression method by super disintegrant addition. Crospovidone and croscarmallose 
sodium are used as superdisintegrants in different concentrations. Croscarmallose in the 
concentration of 5% showed minimum disintegration time and wetting time as compared to 
other formulations. The results showed that disintegration time increased with the type of 
superdisintegrant. 
Aiman A. Obaidat et al., 2010, Development and Evaluation of Fast Dissolving Tablets of 
Meloxicam- ß-Cyclodexrin complex prepared by direct compression. A complex of 
meloxicam with ß-Cd was prepared by spray drying and then compressed in the term of 
tablets by direct compression using various levels of three types disintegrants crospovidone, 
croscarmallose sodium and sodium starch glycolate. Co-spray dried mannitol were and as 
diluents. Formulation containing 6% of croscarmallose sodium, as superdisintegrant showed 
shortest disintegration time and higher release rate than other formulations. It was concluded 
that complexation of melaxicam with ß-Cd provides greatest drug release. 
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CHAPTER-IV 
AIM OF THE WORK 
The aim of present work is to formulate and evaluate Fast Dissolving Tablets of 
Lamivudine to prevent MTCT (Mother to Child Transmission) of HIV virus in perinatal 
infants. 
Lamivudine, a synthetic nucleoside analogue with activity against HIV-1 and 
HBV. The chemical name of lamivudine is (2R, cis)-4-amino-1-(2-hydroxymethyl-1-3, 3-
oxathiolan-5-yl)-(IH)-pyrimidin-2-one.The solubility of lamivudine is approximately 
70mg/ml in water at 20ºc (Narasimharao et al., 2011). 
Rationale behind the devolepment of Fast Dissolving Tablets of Lamivudine (30mg) 
MTCT is typically addressed by suppression of virus in mother or by limiting 
child’s exposure to the various body fluids during child birth, for example by utilizing 
caesarian section birth. However, in addition to potential exposure to HIV in utero and 
during birth, new borns may also face continued exposure to HIV through breast feeding. 
Thus an alternative approach to reduce incidents of MTCT of HIV is to administer a 
single entity anti-retiroviral drug to the new born. While anti-retiroviral “cocktails” may 
be used to treat adult patients with HIV/AIDS, such drug combinations may not be 
necessary or desirable for preventing MTCT of virus in perinatal infants. First, the 
maturity of the virus in the newborn is typically less than in infected adults. That is, the 
virus in perinatal children has no time or oppurtunity to mutate and devolep drug 
resistance. Thus, treatment with single antiretiroviral entities may effectively reduce the 
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MTCT without need to rely on multicomponent anti-retiroviral cocktails. Further 
significant toxicities are associated with antiviral drug cocktails, which may cause 
undesirable side effects upon administration to the developing physiology of the perinatal 
or infants (Adeyeye et al., 2011). 
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CHAPTER-V 
PLAN OF WORK 
 
PART I 
1. Determination of λmax for Lamivudine. 
2. Calibration of Lamivudine. 
                                     
PART-II  
1. Preformulation evaluations 
a) Differential Scanning Colorimetry (DSC) Studies 
b) Fourier Transmission Infra-Red (FT-IR) Studies  
PART-III 
1. Precompression evaluations of all the formulations 
 
PART -IV 
1. Formulation of Fast Dissolving Tablets of Lamivudine using various 
superdisintegrants at different ratios by direct compression method 
PART-V 
1. Post compression evaluations for tablets of all formulations. 
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CHAPTER-VI 
MATERIALS AND EQUIPMENTS 
 
MATERIALS 
 
                                  SUPPLIERS 
 
Lamivudine 
 
Strides Acrolabs, Bangalore, India. 
 
Sodium starch glycolate 
 
Octis Research Lab, Uttarkhand, India. 
 
Crospovidone 
 
Octis Research Lab, Uttarkhand, India. 
 
Croscarmellose sodium 
 
Octis Research Lab, Uttarkhand, India 
 
Microcrystalline cellulose 
 
High purity laboratory chemicals, Mumbai, India. 
 
Mannitol 
 
Universal Scientific Appliances, Madurai, India. 
 
Saccharin sodium 
 
Universal Scientific Appliances, Madurai,India. 
 
Magnesium stearate 
 
Universal Scientific Appliances, Madurai, India 
 
Talc 
 
Universal Scientific Appliances, Madurai. India 
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EQUIPMENTS 
 
SUPPLIERS 
 
Electronic Weighing Balance 
 
A & D Company HR 200, Japan. 
 
Single Punch Tablet Compression Machine 
 
Cadmach, Ahmedabad, India. 
 
UV- Visible Spectrophotometer 
 
Shimadzu, Japan. 
 
Digital Tablet Dissolution Test Apparatus 
 
Disso 2000, Lab India, New Mumbai, India. 
 
Friability Test Apparatus 
 
Indian Equipment Corporation, Mumbai, 
 
Hot Air Oven 
 
Rands Instruments, Chennai, India. 
 
Disintegration Test Apparutus 
 
Rolex, India. 
 
Tablets hardness tester (Monsanto) 
 
Pravin Enterprises, Bangalore, India. 
 
Vernier Caliper 
 
Linker, India. 
 
Differential Scanning Calorimeter 
 
T.A.Instrument, USA. 
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CHAPTER-VII 
DRUG PROFILE 
Name:    
                      Lamivudine 
Description: 
 A Reverse transcriptase inhibitor and zalcitabine analog in which a sulphur atom 
replaces the 3’ carbon o the pentose ring. It is used to treat HumanImmunodeficiency 
Virus Type 1 (HIV-1) and hepatitis-B  (HBV).  
Molecular weight:      229.256 
Structure:  
 
Chemical Formula:    C8H11N3O3S 
IUPAC Name:           4-amino-1-[(2R,5S)-2-(hydroxymethl)-1,3-oxathiolan-5yl]-1,2-  
                                  dihydropyrimidin-2-one          
Indication:                 For the treatment of HIV infection and chronic hepatitis-B (HBV) 
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Pharmaco-dynamics:   
Lamivudine is a nucleoside reverse transcriptase inhibitor(NRTI) with activity 
against Human Imunodeficiency Virus Type 1 (HIV1) and hepatitis-B 
(HBV).Lamivudine is phosphorylated to active metabolites that compete for 
incorporation in to viral DNA. They inhibit the HIV reverse transcriptase enzyme 
completely and act as a chain terminater of DNA synthesis.The lack of a 3’-OH group 
in the incorporated nucleoside analogue prevents the formation of the 5’to 3’   
phosphodiester linkage essential for DNA growth is terminated. 
Mechanism of action:               
         Lamivudine is asynthetic  nucleoside analogue and is phosphorylated 
intracellularly to its active 5’-triphosphate metabolite,lamivudine    triphosphate (L-
TP).This nucleosid analogue is incorporated into viral DNA by HIV reverse 
transcriptase and HBV polymerase,resulting in  DNA chain termination. 
Absorption:                 
Lamivudine is rapidly absorbed after oral administration in HIV infected 
patients.                                                           
Bioavailability:                      86% ± 16% for tablet and 87% ± 13% 
Protein binding:                   36% 
Metabolism:                         The only metabolite of lamivudine is trans-sulfoxide. 
Route of elimination:           Lamivudine is excreted unchanged in urine and, also is  
                                                excreted in human breast milk.                           
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Half life:                     5 to 7 hrs 
Clearance:                  Renal clearance = 280.4 ± 75.2 ml / min [HIV – infected patients  
                                    given a single dose IV ranging from 0.25 to 8mg/kg] 
Melting point:            160 to162
º
c. 
Solubility:                  7mg/ml in water at 20
 º
c 
Dosage:                     
                                   HIV – 300mg as single or two divided doses. 
                                   HBV – 100mg OD 
                                   HIV – Infants and children 
                           Over 3 months of age  and weighing less than 14kg or in those 
unable   to swallow oral solution – 4mg/kg b.i.d to a maximum of 300mg. 
 Weighing 14 to 21 kg – Tablet in a dose of 75mg b.i.d. 
Weighing 21to 30 kg – 7mg in morning and 150mg at night. 
Over 30 kg – 150mg b.i.d. 
Dosage reduction is needed in HIV patients of 3 months age and    weighing not  
less than 30kg with moderate to severe renal impairment  
 i.e., CC below 50ml/min. 
   CC below 30 to 49ml/min – 4mg first dose and then 4mg/kg O.D 
   CC 15 to 29ml/min -4mg/kg first dose and then 2.6mg/kg O.D 
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  CC 5 to 14ml/min – 4mg/kg first dose and then 1.3mg/kg O.D 
  CC less than 5ml/min -1.3mg/kg first dose and then 0.7mg/kgO.D 
  Chronic Hep-B in children between 2 to 17 years – 3mg/kg O.D to       maximum 
of 100mg.                                     
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CHAPTER-VIII 
 
CROSPOVIDONE 
 
Synonyms: 
• Cross linked Povidone. 
•  Kollidon. 
•  Polyplasdone. 
•  Polyvinylpoly pyrrolidone. 
•  1-vinyl-2-pyrrolidinone homopolymer. 
 
Chemical Name: 
                  1-Ethenyl-2-pyrrolidinone homopolymer.  
Chemical Structure: 
 
                            
Empirical formula: 
                                                             (C6H9NO)n  
 
Molecular Weight:   
                                                    >1 000 000 
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Functional category: 
                                     Tablet disintegrant. 
 
 Application in Pharmaceutical formulation: 
• Tablet disintegrant and dissolution agent.  
•  Solubility enhancer for poorly soluble drug. 
 
Description: 
                   Crospovidone is a white to creamy-white, finely divided, freeflowing, 
practically tasteless, odorless or nearly odourless, hygroscopic powder. 
 Stability and storage condition: 
Crospovidone is hygroscopic, it should be stored in an airtight container in a 
cool, dry place. 
 Incompatibilities: 
Crospovidone is compatible with most organic and inorganic pharmaceutical 
ingredients. When exposed to a high water level, crospovidone may form molecular 
adduct with some materials. 
 Handling Precautions: 
Observe normal precautions appropriate to the circumstances and quantity of 
material handled. Eye protection, gloves, and a dust mask are recommended. (Hand 
book of Pharmaceutical excipients-5
th
 edition, 214-216) 
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                                           CROSCARMELLOSE SODIUM 
Synonyms: 
• Ac-Di-Sol. 
•  Cross linked carboxymethylcellulose sodium. 
•  Explocel. 
•  Modified cellulose gum. 
•  Primellose. 
•  Solutab. 
•  Vivasol. 
Chemical Name: 
                                     Cross linked   carboxy methyl ether Cellulose sodium salt.  
Functional Category: 
                      Tablet and capsule disintegrant. 
Applications in Pharmaceutical Formulation: 
                      Disintegrating agent for tablets and capsules. 
Description: 
                             -White or grayish white powder. 
                            -Odourless and tasteless. 
                            -Insoluble in water. Practically insoluble in acetone, ethanol and 
                             toluene  . 
Pharmacopoeial Specifications: 
                                pH (1% w/v dispersion) 5.0–7.0 
                                Loss on drying ≤10% 
                                Heavy metals ≤10 ppm 
                              Sodium chloride and sodium glycolate	≤ 0.5% 
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                              Sulfated ash 14.0–28.0%  
                              Settling volume 10.0–30.0 ml 
                              Acidity/alkalinity: pH = 5.0–7.0 in aqueous dispersions. 
                              Density (bulk): 0.529 g/cm3  
                               Density (tapped): 0.819 g/cm3  
                              Density (true): 1.543 g/cm3  
Stability and Storage Conditions: 
Croscarmellose sodium should be stored in a well-closed container in a cool, dry 
place. 
Incompatibilities: 
 Croscarmellose sodium is not compatible with strong acids or with soluble salts 
of iron and some other metals such as aluminum, mercury, and zinc. 
Handling Precautions: 
 Croscarmellose sodium may be irritant to the eyes; eye protection is 
recommended (Hand book of Pharmaceutical excipients-5
th
 edition, 211-213). 
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                                   SODIUM STARCH GLYCOLATE 
Synonyms: 
•  Explosol. 
•  Explotab. 
•  Primojel. 
• Starch carboxymethyl ether, sodium salt. 
• Tablo. 
• Vivastar P. 
Chemical Name: 
                              Sodium carboxymethyl starch. 
Chemical structure: 
                       
Functional Category: 
                            Tablet and capsule disintegrant. 
Application in Pharmaceutical Formulation: 
• Sodium starch glycolate is  used as a disintegrant in capsule and tablet 
formulations. 
• Sodium starch glycolate is also used as a suspending vehicle. 
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Description 
• Sodium starch glycolate is a white to off-white, odorless, tasteless, free flowing 
powder 
• It does not melt, but chars at approximately 200
o
C 
• It is sparingly soluble in ethanol (95%) but practically insoluble in water. 
Pharmacopoeial Specifications: 
• Specific surface area: 0.24m2/g; 
• Swelling capacity: In water, sodium starch glycolate swells to up to 300 times 
its volume. 
• Viscosity (dynamic): 4200 mPa s (200 cP) for a 4% w/v aqueous dispersion. 
• Viscosity is 4.26 mPa s for a 2% w/v aqueous dispersion. 
Stability and Storage Conditions: 
 Sodium starch glycolate should be stored in a well-closed container in order to 
protect it from wide variations of humidity and temperature, which may cause caking. 
Incompatibilities: 
Sodium starch glycolate is incompatible with ascorbic acid. 
Handling Precautions: 
Sodium starch glycolate may be irritant to the eyes; eye protection and gloves 
are recommended. .(Hand book of Pharmaceutical excipients-5
th
 edition) 
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 Synonyms: 
• Magnesium
• Octadecano
• Stearic acid
Chemical Name: 
                        Oct
Structural Formula: 
                       [CH
Molecular Structure: 
              
 
Empirical Formula and
                             
Functional Category: 
Tablet and capsule
Application in Pharmace
• Lubricant in capsu
• Magnesium steara
formulations.  
                                                          EXCIPI
 
  MAGNESIUM STEARATE 
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•  It is also used in barrier creams. 
Description: 
• Magnesium stearate is a very fine, light white powder. 
• Faint odour. 
• Characteristic taste. 
• Greasy to the touch and readily adheres to the skin.  
Pharmacopoeial Specifications: 
Freezing point 5538C 
Nickel 45 ppm 
Cadmium 43 ppm 
Loss on drying 46.0% 
Chloride 40.1% 
Sulfate 41.0% 
Lead 410 ppm 
 
Stability and Storage Conditions: 
           Magnesium stearate should be stored in a well closed container in a cool, dry 
place. 
Incompatibilities: 
Incompatible with strong acids, alkalis, and iron salts. Avoid mixing with strong 
oxidizing materials. Magnesium stearate cannot be used in products containing aspirin, 
some vitamins, and most alkaloidal salts. 
Safety: 
Oral consumption of large quantities may produce a laxative effect or mucosal 
irritation.  
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Handling Precautions: 
- Eye protection an
-Excessive inhalat
tract discomfort, coughin
edition,430-433)  
Synonyms: 
• Cordycepic
•  Manna sug
• D-Mannite
•  Pearlitol.
Chemical Name:  
                             
Chemical structure: 
  
Empirical Formula and
                             
Functional Category: 
• Diluent. 
•  Sweetenin
•  Tonicity 
                                                          EXCIPI
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Application in Pharmaceutical Formulation: 
• Mannitol is widely used in pharmaceutical formulations and food 
products.  
• It is used as diluents (10–90% w/w) in tablet formulations. 
• Mannitol is commonly used as an excipient in the manufacture of 
chewable tablet formulations. 
•  Plasticizer in soft-gelatin capsules, as a component of sustained-release 
tablet formulation. 
• It is used as a carrier in dry powder inhalers. 
• It is also used as diluents in rapidly dispersing oral dosage forms. 
• It is used in food applications as a bulking agent. 
 
Description: 
• Mannitol is a white, odorless, crystalline powder, or free-flowing 
granules. 
• It has a sweet taste. 
•  Microscopically, it appears as orthorhombic needles when crystallized 
from alcohol. 
•  Mannitol shows polymorphism.  
• Pharmacopoeial Specifications: 
• Density (bulk):0.430 g/cm3. 
• Density (tapped):0.734 g/cm3. 
• Density (true): 1.514 g/cm3. 
• Dissociation constant: pKa = 13.5 at 188C. 
• Flowability: powder is cohesive, granules are free flowing. 
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• Melting point: 166–168
o
C 
• Loss on drying:  40.3%  
Stability and Storage Conditions: 
 It should be stored in a well-closed container in a cool, dry place. 
Incompatibilities: 
• Mannitol solutions, 20% w/v or stronger, may be salted out by potassium 
chloride or sodium chloride. 
•  Mannitol is incompatible with xylitol infusion and may form complexes 
with some metals such as aluminum, copper, and iron. 
•  Reducing sugar impurities in mannitol have been implicated in the 
oxidative degradation of a peptide in a lyophilized formation.  
Handling Precautions: 
Mannitol may be irritant to the eyes; eye protection is recommended. . (Hand 
book of Pharmaceutical excipients-5
th
 edition,449-453) 
 
                                    MICROCRYSTALLINE CELLULOSE 
Synonyms: 
• Avicel PH. 
•  Celex. 
•  Celphere. 
•  Ceolus KG. 
•  Ethispheres. 
•  Fibrocel. 
•  Pharmacel.  
• Tabulose. 
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•  Vivapur. 
Chemical Name: 
                 Cellulose. 
Empirical Formula: 
               (C6H10O5) n  
Molecular Weight: 
                36 000 
Functional Category: 
• Adsorbent. 
•  Suspending agent, Tablet and capsule diluents, tablet disintegrant. 
Application in Pharmaceutical Formulation: 
• Microcrystalline cellulose is used as a binder/diluent in oral tablet and 
capsule formulations.  
• Microcrystalline cellulose is used as a lubricant and disintegrant agent in 
tablet formulation. 
• Microcrystalline cellulose is also used in cosmetics and food products.  
Description: 
Microcrystalline cellulose is a white, odorless, tasteless, crystalline powder 
composed of porous particles.  
                                              Use Concentration (%) 
• Adsorbent: 20–90 
• Antiadherent: 5–20 
• Capsule binder/diluent: 20–90 
• Tablet disintegrant : 5–15 
• Tablet binder/diluents: 20–90 
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Pharmacopoeial Specifications: 
• pH: 5.0–7.0  
• Loss on drying: 47.0%  
• Residue on ignition: 40.05% 
• Sulfated ash: 40.1% 
• Heavy metals: 410 ppm  
Typical Properties: 
• Density (tapped):0.478 g/cm3, 
• Density (true): 1.512–1.668 g/cm3 
• Flowability: 1.41 g/s for Emcocel 90M. 
• Melting point: chars at 260–2708C. 
• Microcrystalline cellulose is hygroscopic. 
Stability and Storage Conditions: 
Microcrystalline cellulose is a stable though hygroscopic material. The bulk 
material should be stored in a well-closed container in a cool, dry place. 
Incompatibilities: 
Microcrystalline cellulose is incompatible with strong oxidizing agents. 
Handling Precautions: 
 Microcrystalline cellulose may be irritant to the eyes. Gloves, eye protection, 
and a dust mask are recommended. .(Hand book of Pharmaceutical excipients-5
th
 
edition132-135, ) 
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                          SACCHARIN SODIUM    
 
Synonyms: 
                      1,2-Benzisothiazolin-3-one 1,1-dioxide, sodium salt; Crystallose E954; 
sodium o-benzosulfimide; soluble gluside; soluble saccharin; sucaryl sodium. 
 
Chemical Name; 
                        1,2-Benzisothiazol-3(2H)-one 1,1-dioxide, sodium salt  for the dihydrate 
 for the anhydrous material. 
 
Chemical structure: 
                      
Empirical Formula and Molecular Weight: 
                                                      C7H4NNaO3S 205.16 
Functional Category: 
                                                      Sweetening agent. 
Application in Pharmaceutical Formulation: 
                               Saccharin sodium is an intense sweetening agent used in beverages, 
food products, table-top sweeteners and pharmaceutical formulations such as tablets, 
powders, medicated confectionery, gels, suspensions, liquids, and mouthwashes; It is 
also used in vitamin preparations. 
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  Uses of saccharin sodium 
• Dental paste/gel 0.12–0.3% 
• IM/IV injections 0.9% 
• Oral solution 0.075–0.6% 
Description: 
                        Saccharin sodium occurs as a white, odorless or faintly aromatic, 
efflorescent, crystalline powder. It has an intensely sweet taste, with a metallic 
aftertaste that at normal levels of use can be detected by approximately 25% of the 
population. Saccharin sodium can contain variable amounts of water. 
 
Pharmacopoeial Specification: 
• Water 415.0%  
• Arsenic 42 ppm 
• Selenium 40.003% 
• Heavy metals 420 ppm  
• Assay (anhydrous basis) 99.0–101.0%  
 
• Typical Properties: 
• Acidity/alkalinity: pH = 6.6 (10% w/v aqueous solution) 
• Density (bulk):0.8–1.1 g/cm3  
• Density (particle): 1.70 g/cm3 
• Density (tapped): 0.9–1.2 g/cm3  
• Moisture content: 14.5% w/w water;  
• Solvent Solubility at 208C 
• Specific surface area: 0.25m2/g                
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Stability and Storage Conditions: 
              Saccharin sodium is stable under the normal range of conditions employed in 
formulations. Saccharin sodium should be stored in a well-closed container in a cool, 
dry place. 
 
Handling Precautions: 
               Observe normal precautions appropriate to the circumstances and quantity of 
material handled. Eye protection and a dust mask are recommended. .(Hand book of 
Pharmaceutican excipients-5
th
 edition) 
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                                                                    TALC 
Synonyms: 
Altalc, E553b, hydrous magnesium calcium silicate, hydrous magnesium 
silicate, Luzenac Pharma, magnesium hydrogen metasilicate, Magsil Osmanthus, 
Magsil Star, powdered talc, purified French chalk, Purtalc, soapstone, steatite, 
Superiore. 
Chemical Name: 
                                  Talc  
Empirical Formula: 
                                Mg6(Si2O5)4(OH)4. 
 
Chemical Structure: 
                          
Functional Category: 
Anticaking agent, glidant, tablet and capsule diluent, tablet and capsule 
lubricant. 
Applications in Pharmaceutical Formulations: 
 Lubricant and diluents. 
 Dissolution retardant in the development of controlled-release products. 
 An adsorbant. 
 Dusting powder. 
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  Talc is additionally used to clarify liquids and is also used in cosmetics and 
food products, mainly for its lubricant properties. 
                                           Dusting powder: 90.0–99.0% 
                                           Glidant and tablet lubricant: 1.0–10.0% 
                                            Tablet and capsule diluents: 5.0–30.0% 
Description: 
Talc is a very fine, white to grayish-white, odorless, impalpable, unctuous, 
crystalline powder. It adheres readily to the skin and is soft to the touch and free from 
grittiness. 
Pharmacopoeial Specifications: 
 Acidity/alkalinity: pH = 7–10 for a 20% w/v aqueous dispersion. 
 Hardness (Mohs): 1.0–1.5 
 Solubility: practically insoluble in dilute acids and alkalis, organic 
solvents, and water. 
 Specific gravity: 2.7–2.8 
 Specific surface area: 2.41–2.42m2/g 
Stability and Storage Conditions: 
Talc is a stable material and may be sterilized by heating at 1608C for not less 
than 1 hour. It may also be sterilized by exposure to ethylene oxide or gamma 
irradiation.Talc should be stored in a well-closed container in a cool, dry place. 
Incompatibilities: 
Incompatible with quaternary ammonium compounds. 
Handling Precautions: 
 Talc is irritant if inhaled and prolonged excessive exposure may cause 
pneumoconiosis. In the UK, the occupational exposure limit for talc is 1 mg/m3 of 
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respirable dust long-term (8-hour TWA).Eye protection, gloves, and a respirator are 
recommended (Handbook of Pharmaceutical excipients- 5
th
 edition, 641-643). 
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CHAPTER- IX 
EXPERIMENTAL DETAILS 
1. CALIBRATION OF LAMIVUDINE 
An accurately weighed quantity of 100mg lamivudine pure drug is taken in a 
100ml standard flask. It is mixed with sufficient quantity of distilled water and shaken 
well until the drug is completely dissolved. From this, 10ml of the solution is pipetted 
out and made up to 100ml with distilled water. From this 5,10,15,20 and 25ml of 
solutions are pipetted out in separate standard flasks and the volume is made up to 
100ml with distilled water. The absorbance is measured at 271nm in UV-
Spectrophotometer. 
2. PREFORMULATION EVALUATIONS 
a) Differential Scanning Calorimetry (DSC) Studies 
DSC analysis (DSC200 TA instruments, USA) of samples are carried out by heating the 
samples under nitrogen atmosphere on an aluminium pan at a heating rate of 10
º
C / min, 
over the temperature range 5 - 200
 º
C and a nitrogen gas flow of 20 lb / cm
2
. 
b) Fourier Transmission Infra-Red (FT-IR) Studies  
The studies are performed to check the compatability of drug and excipients used in the 
formulation in order to prevent degradation by interaction. FT-IR spectra (Spectrum RX 
-1 Perkin-Elmer, German) for the drug and various physical mixtures are obtained in a 
FT-IR spectroscopy in the transmission mode with a wave number region 4000 – 400 
cm
-1
.KBr pellets are prepared gently by mixing 1mg sample powder with 100mg KBr.  
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3. FORMULATION OF FAST DISSOLVING TABLETS OF LAMIVUDINE 
 The Fast dissolving tablets of lamivudine were prepared by direct compression 
method. Three different superdisintegrants are used namely  
• Croscarmallose sodium 
• Sodium starch glycolate 
• Crospovidone 
Fifteen formulations were prepared using different superdisintegrants for each of 
five formulations, in a concentration ranging from 2% to 10% (2, 4, 6, 8 &10). An 
accurately weighed quantity of drug, superdisintegrants & microcrystalline cellulose are 
taken in a glass mortar and ground well, the other excipients like mannitol, sodium 
saccharin, magnesium stearate and talc are added in an order and mixed well to ensure 
thorough mixing of all ingredients. Then the powder is analysed for flow properties like 
• Angle of repose 
• Bulk density 
• Tapped density 
• Compressibility Index 
• Hausner’s ratio 
       The total powder blend is weighed individually for fifty tablets for each 
formulation, as per the calculations derived from the drug content of the powder blend. 
Then the individually weighed powders are compressed in the tablet compressing 
machine. 
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4. PRECOMPRESSION EVALUATIONS FOR THE POWDER BLEND  
The prepared blend was evaluated by following tests. 
• Angle of repose 
• Bulk density 
• Tapped density 
• Carr’s index 
• Hausner’s ratio 
a. Angle of repose 
Angle of repose is determined by using funnel method. The accurately weighed 
blend is taken in a funnel. The height of the funnel is adjusted in such a way that the tip 
of the funnel just touches the apex of the heap of blend. The drug- excipient blend is 
allowed to flow through the funnel freely on the surface of a paper. The diameter of the 
powder cone is measured and angle of repose is calculated using the following equation 
(Amrutkar et al ., 2010) 
Tan ɵ = h/r 
Where  
h = height of the cone 
r = radius of the cone 
b. Bulk density 
Apparent bulk density is determined by pouring a weighed quantity of blend in 
to a graduated cylinder and measuring the volume and weight. (Vijay Tiwari et al., 
2010) 
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                                     Weight of the powder 
Bulk Density =        ----------------------------------------  
                             Volume of packing 
c. Tapped Density 
The tapped density is determined by placing a graduated cylinder, containing a 
known mass of drug - excipients blend. The cylinder is tapped on a flat surface from a 
height of 10cm at 2 seconds intervals. The tapping is continued until no further change 
in volume is noted (Suhas M.Kakade et al., 2010) 
      Weight of the powder 
   Tapped density=   -------------------------------------- 
         Tapped volume 
d. Compressibility Index 
The compressibility index of the blend is determined by carr’s compressibility index. 
(Gnanaprakash et al., 2010) 
                                                                           Tapped density-bulk density 
Carr’s compressibility index= ----------------------------------------- X 100
  
                                                                                     Tapped density 
.   
e. Hausner’s ratio 
            Hausner’s ratio is determined by the following formula: (Debijit Bhoumik et al., 
2009) 
                                                                Tapped density 
                              Hausner’s ratio =    ------------------------- 
                                                                   Bulk density 
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5. POST COMPRESSION EVALUATION 
a. Hardness 
The hardness of the tablets is an indication of its strength measuring the force 
required to break the tablet across tests it. The force is measured in kg and hardness of 
about 3-5kg/cm
2
 is considered to be satisfactory for uncoated tablets. Hardness of ten 
tablets from each formulation was determined by using mansanto hardness tester. 
(Kolhe et al., 2011) 
b. Thickness  
 Thickness of the tablets is determined by using vernier calliper. (Althaf et al., 
2011) 
c. Diameter 
 The diameter of the tablets is determined by using vernier calliper.(Ravikumar 
et al., 2009) 
d. Drug content 
Five tablets from each batch are weighed and powdered, 10mg equivalent of the 
powder is taken and diluted with 10ml of distilled water and the volume is made up to 
100 ml. From this 10ml of the solution is taken and the volume is made up to 100ml 
with distilled water. The absorbance of the solution is measured using UV-
Spectrophotometer at 271 nm. (C.P Jain et al., 2009) 
e. Weight variation test 
Twenty tablets are taken and their weight is determined individually and 
collectively on a digital weighing balance the average weight of one tablet is 
determined from the collective weight. (P.S Kwtikwar et al., 2009) 
USP specification for the uniformity of weight   
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S.NO. 
 
AVERAGE WEIGHT (mg) 
MAXIMUM % 
DIFFERENCE 
ALLOWED 
1 130 or less 10% 
2 130-324 mg 7.5% 
3 More than 324 mg 5% 
 
f. Friability 
 Friability is the loss of weight of tablet in the container due to removal of 
particles from surface. Friability test is carried out to access the ability of the tablet to 
withstand abrasion in packaging, handling and transport. Roche friabilator is employed 
for finding the friability of tablets.20 tablets from each formulation are employed for 
finding the friability of tablets. The tablets are weighed and placed in roche friabilator. 
That is rotated at 25 rpm for 4 min. The tablets are dusted and weighed again .The 
percentage of weight loss is calculated again using the formula (Harish chander et al., 
2011). 
 
                                         Initial weight- final weight 
Percentage friability = ---------------------------------------- X 100 
                                                  Initial weight 
 
g. Wetting time and Water absorption ratio 
   For determination wetting time and water absorption ratio, a piece of tissue paper is 
folded twice and placed in a small petridish (having internal diameter of 5 cm) 
containing 6 ml of water .a small quantity of amaranth red dye is added to the water. A 
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tablet is placed on the paper and the time required for the complete wetting is measured 
.The wetted tablet is then weighed (M.V Rampure et al., 2010). The water absorption 
ratio ‘R’ is determined using the equation 
                                Wa - Wb 
                      R= ----------------- X 100 
                                    Wb 
 
Where, 
     Wa =Weight of the tablet after water absorption. 
    Wb = Weight of the tablet before water absorption. 
 
 
h. Disintegration test 
                    The disintegration test is performed using an USP disintegration apparatus 
with distilled water at 27±	0.5℃		.the time reported to obtain complete disintegration of 
6 tablets are recorded and average is reported (Viral shah et al., 2011). 
i. Dissolution Studies 
The release rate of the formulated Lamivudine tablets are characterized using 
USP type 2(Paddle) at 50rpm, 900ml of distilled water is used as dissolution 
medium.10mlof samples are withdrawn from the dissolution medium and replace with 
10ml of blank media. The samples are withdrawn at 5,10,15,30 and 45 mins, and 
analysed using UV-Spectrophotometer. Results of the dissolution rate are recorded 
(K.Prakash et al.,2008). 
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CHAPTER-X 
RESULTS AND DISCUSSION 
1. CALIBRATION OF LAMIVUDINE 
The ƛmax of Lamivudine was determined by scanning the 10µg / ml solution of 
drug using UV-Spectrophotometer and was found to be 271nm.The absorbance of the 
solution 5 to 25  µg/ml was measured in UV-Spectrophotometer at 271nm.(Table-1). 
The linear correlation was found to be 0.9995(Distilled water) (Fig- 1) 
2. PREFOFORMULATION EVALUATIONS 
a) Differential Scanning Calorimetry (DSC) Studies 
DSC experiments are carried out in order to characterise the physical state of 
drugs in formulation. The thermograms of pure drug exhibit the single isothermic 
peak at 177.4
º
c. In thermogram of physical mixture of drug with excipients, the drug 
peaks were shifted to lower temperature with reduced intensity which may due to 
baseline shift. Baseline shift are caused by changes in sample weight or specific heat 
of sample.( Fig- 5 to 10) 
b) Fourier Transmission Infra –Red (FT-IR) Studies 
Before formulation, preformulation study was carried out by comparing FT-IR 
spectra of pure Lamivudine and its physical mixture with superdisintegrants using 
Fourier Transmission Infrared spectrophotometer. There was no difference in their 
spectra. It was observed that the drug remained intact in the presence of 
superdisintegrants.   ( Fig -11 to 15)  
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3. FORMULATION OF FAST DISSOLVING TABLETS OF LAMIVUDINE 
The individually weighed powder blends of each formulation were 
compressed in to tablets in a single punch tablet compressing machine. Fifty tablets 
for each formulation were obtained. The tablets were white in colour and round in 
shape. The contents for tablets of each formulation were shown in Table -02 
4. PRECOMPRESSION EVALUATIONS FOR THE POWDER BLEND 
Precompression evaluations were done to ensure the flow properties of the 
powder blend .Good flow properties of the powder blend will yield the tablets of 
desired quality and ease the tableting process. So it was mandatory to assess the 
flowability of the blend before compression. The various precompression evaluations 
were as follows 
• Angle of repose 
• Bulk density 
• Tapped density 
• Compressibility Index 
• Hausner’s ratio 
a. Angle of repose 
The angle of repose was used for the measurement of frictional force in a 
loose powder which in turn will influence the flow properties of the powder blend. 
The angle repose of all the formulations ranges from 30˚.06’ to 30˚ .72’.It was evident 
from the results, that the powder blends of all formulations posses’ good flow 
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properties. The results of angle of repose for all the formulations were summarised in 
Table – 03 (Amrutkaret al., 2010). 
b. Bulk density 
The bulk density was determined to assess the free flowing property of the 
powder blend. The bulk density of all formulations ranges from 0.3368g/cm
3 
to 
0.3916g/cm
3
. The results indicate that the powder blends of all fifteen formulations 
were having good flow properties. The results were summarised in Table-03(Vijay 
Tiwari et al., 2010). 
c. Tapped density 
The tapped densities of all fifteen formulations were determined to analyse the 
powder blends for their free flowing property. The tapped density of all the 
formulations ranges from 0.4436g/cm
3
 to 0.4663g/cm
3
. From the results, it was 
inferred that the powder blend of all formulations posses good flow properties. The 
results of all the formulations were summarised in Table -03(Suhas M. Kakade et al., 
2010). 
d. Compressibility Index  
The compressibility index was the simplest method to measure the free 
flowing of   powder blends of all formulations. The ease with which a material was 
induced to flow was given by compressibility index. The compressibility index of all 
the formulations ranges from 15.9 to 24.14.The results indicate that the powder blend 
of all formulations possess good flow properties. The results of all formulations were 
summarised in Table -03  (K.Gnanaprakashet al., 2009). 
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e. Hausner’s ratio 
The Hausner’s ratio was an indirect index of ease of powder to flow. The 
Hausner’s ratio for powder blends of all fifteen formulations ranges from 1.18 to 
1.31.It was observed from the results that the powder blends of all formulations have 
good flow properties except for formulations (F1, F4, F5) .The results were 
summarised in Table – 03. 
Hausner’s ratio 
˂ 1.25 – Good flow property 
>1.25 – poor flow property (Debijit Bhowmik et al., 2009) 
It was evident from the results of the precompression studies, that the powder blends 
of all fifteen formulations posses good flow properties, which were within the 
standard limits and were qualified for compression into Tablets. 
5. POST COMPRESSION EVALUATIONS  
The tablets obtained after compression were evaluated on various parameters  
to determine their quality and to ensure that the resultant product meets all necessary 
criteria’s required for the fast dissolving tablets. 
a. Hardness 
The hardness for tablets determines the resistance of the tablets to abrasion or 
breakage under conditions of storage, transformation and handling before usage. The 
hardness for tablets of all the fifteen formulations was found to be 3kg/cm
3
.The 
results indicate that the tablets of all formulations have uniform hardness, which in 
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turn protect them from mechanical damage .The results were summarised in Table -04 
(Kolhe et al., 2011). 
 
  
b. Thickness 
The thickness of tablets gives appearance, prevents damage from external 
forces and ensures uniform die filling of the powder blends. The thickness for Tablets 
of all fifteen formulations was found to be 3mm.The results indicate that the Tablets 
of all formulations were of uniform size. The results were summarised in Table -04 
(Althaf et al ., 2011). 
c. Diameter 
The diameter was measured to ensure the uniformity in size and shape of the 
Tablets. The diameter of all fifteen formulations was found to be 8mm.The results 
indicate that the Tablets of all batches were of uniform size and shape. The results 
were summarised in Table -04. (Ravikumar et al ., 2009) 
d. Drug content 
The drug content of the tablets was estimated to ensure that all the tablets of a 
formulation contains the therapeutic dosage of the active ingredient meant for the 
particular dosage form. The drug contents for tablets of all the formulations ranges 
from 95.74% to 97.16%.The results indicate that the contents for tablets of all 
formulations were uniform and contains therapeutic dose of the active ingredient. The 
results were summarised in Table -04 (C.P Jain et al., 2009). 
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e. Weight variation test 
The weight variation test was carried out to ensure that the tablets of each 
formulation were of uniform weight, which in turn will indicate the uniform 
distribution of contents of the powder blends of each formulations. The weight 
variation for tablets of all formulations was found to be within the range of ±7.5%. 
The results indicate that all tablets of each formulation were of uniform weight. The 
results were shown in Table-04 (P.S Kawtikwar et al., 2009) 
f. Friability test 
The friability test was carried out to ensure the mechanical strength of tablets 
to avoid the loss of the external surface of the tablets during the process of packing, 
handling, transit, and storage. Friability below 1% was an indication of good 
mechanical resistance. The results indicate that the friability for tablets of all 
formulations were below 1%and hence passes the test. The results were summarised 
in Table -04 (Harish Chander et al., 2011). 
g. Wetting time and Water absorption ratio 
The wetting time and water absorption ratio indicates the capacity of the 
superdisintegrants to absorb water and completely wet the tablet at the earliest time 
possible, which were the significant characteristics of fast dissolving tablets. The 
minimum wetting time and maximum water absorption ratio will enable faster 
disintegration of the tablets, which were the prime important criteria for fast 
dissolving tablets. The wetting time for formulations F1, F2, F3, F4, F5, F6, F7, F8, 
F9, F10, F11, F12, F13, F14, F15 were found to be 15, 90, 103, 36, 151, 70, 74, 88, 
57, 100, 74, 30, 25, 24, 19 seconds respectively .The results indicates that the wetting 
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time and water absorption ratio of all tablets were within the limits. The results were 
summarwase-04 (M.V Rampure et al., 2010). 
h. Disintegration time 
 The disintegration time was the time taken by the tablet to break down in to 
small particles, in the presence of aqueous medium. It varies with type and 
concentration of the superdisintegrants incorporated in the formulation. As the name 
implies disintegration time were the prime most criteria for fast dissolving tablets, 
which should be less than 30 secs to 3 minutes as per the standards. The disintegration 
time for formulations F1, F2, F3, F4, F5, F6, F7, F8, F9, F10, F11, F12, F13, F14, 
F15 was found to be 623, 173, 179, 42.6, 311, 217, 91, 171, 120, 150, 72, 87, 29, 21, 
4 respectively. The results indicate that the disintegration time for tablets of all 
formulations are within the limits except for formulations(F1, F5, F6,) were within the 
permissible limits, which indicate that the Tablets of all formulations disintegrate 
quickly. The results were summarised in Table -04 (Viral shah et al., 2011). 
i. Dissolution studies  
The dissolution studies were performed to evaluate the release profile of the 
drug, which relates the percentage of drug release from its dosage form with the 
function of time. The superdisintegrants were added to the solid dosage formulations 
to enhance the disintegration time and thereby enhancing the faster release of active 
drug from its dosage form, which ultimately results in enhanced rates of absorption 
and bioavailability of the drug. The desired quality of fast dissolving tablets was to 
have a maximum release of therapeutic dose at a very minimal time period. The 
maximum drug release at a time period of five minutes is noted for all the 
formulations. The drug release for tablets of all formulations ranges from 19.27 to 
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97.19. The results indicate that the drug release of all the formulations were found to 
be above 80% in five minutes except for formulations ( F1 and F2).The release rate of 
the three superdisintegrants were in the order of  Crospovidone>Sodium Starch 
Glycolate>Croscarmallose. The results were summarised in Table -04. (K. Prakash et 
al., 2008).The graphical representation for the release rates of formulations containing 
three superdisintegrants are as shown in Fig-2, 3, & 4.  
From the results obtained from the post compression studies of tablets of all fifteen 
formulations, the formulation fifteen with concentration of 10% Crospovidone was 
found to be the best formulation with a disintegration time of 4secs, wetting time of 
19secs and drug release of 97.19±0.28 which was the highest of all formulations .The 
results were summarised in Table -04 (K.Prakash et al 2008) 
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TABLE-01   CALIBRATION OF LAMIVUDINE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
              Concentration(µg/ml) 
 
               Absorbance at 271nm 
                            (Avg ± S.D) 
 
1 
 
5 
 
0.197 ± 0.0045 
 
2 
 
10 
 
0.423 ± 0.004 
 
3 
 
15 
 
0.611 ± 0.0024 
 
4 
 
20 
 
0.804 ± 0.005 
 
5 
 
25 
 
1.005 ± 0.0076 
 
                      r
2
=0.9995 
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TABLE -02    FORMULATION OF FAST DISSOLVING TABLETS OF LAMIVUDINE 
 
Ingredients 
 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 F15 
Lamivudine 
 
30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 
Croscarmallose 
sodium 
4 8 12 16 20 - - - - - - - - - - 
Sodium Starch 
Glycolate 
- - - - - 4 8 12 16 20 - - - - - 
Crospovidone 
 
- - - - - - - - - - 4 8 12 16 20 
Mannitol(27.5%) 
 
55 55 55 55 55 55 55 55 55 55 55 55 55 55 55 
Magnesium 
stearate(2%) 
4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
Sodium 
Sacharrin(5%) 
10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
  Talc(0.5%) 1 1 1 1 1 1 1 1 1 1 1 1 
 
1 1 1 
Micro 
Crystalline 
Cellulose 
96 92 88 84 80 96 92 88 84 80 96 92 88 84 80 
Total weight of 
tablet 
200 200 200 200 200 200 200 200 200 200 200 200 200 200 200 
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TABLE 03       PRECOMPRESSION EVALUATIONS 
 
 
Formulation 
code 
Angle of 
repose(˚) 
Bulk density            
(g/cm3) 
Tapped density 
(g/cm3) 
Compressibility 
index(%) 
Hausner’s ratio Drug 
content       
(%) 
F1 30.50 0.3368 0.4440 24.14 1.31 96.92 
F2 31.40 0.3614 0.4436 18.53 1.22 96.69 
F3 30.69 0.3760 0.4655 19.22 1.23 96.92 
F4 30.54 0.3624 0.4660 22.23 1.28 96.45 
F5 30.25 0.3621 0.4656 22.22 1.28 96.69 
F6 30.66 0.3906 0.4650 16 1.19 96.21 
F7 30.56 0.3760 0.4444 15.39 1.18 96.69 
F8 30.54 0.3913 0.4658 15.99 1.19 95.98 
F9 30.46 0.3916 0.4663 16 1.19 96.92 
F10 30.72 0.3915 0.4661 16 1.19 96.21 
F11 30.72 0.3914 0.4659 15.9 1.19 96.45 
F12 30.43 0.3914 0.4660 16 1.19 96.92 
F13 30.59 0.3915 0.4661 16 1.19 96.21 
F14 30.52 0.3913 0.4659 16 1.19 96.21 
F15 30.06 0.3914 0.4660 16 1.19 96.69 
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TABLE -04   POST COMPRESSION EVALUATIONS OF FAST DISSOLVING TABLETS OF LAMIVUDINE 
 
 
Formulation 
code 
Hardness 
(kg/cm
3) 
Thickness  
(mm) 
 
Diameter  
( mm) 
 
Drug 
content 
( %) 
Weight 
variation(mg) 
Friability 
(%) 
Wetting 
time 
( sec) 
Water 
absorption 
ratio in (%) 
Disintegration 
time 
( sec) 
% drug release in 
5 minutes 
F1 3 3 8 95.74 184.1 -214.04 0.51 15 75.22 623 19.27±0.56 
F2 3 3 8 96.21 184.47-214.27 0.72 90 113 173 77.60±0.76 
F3 3 3 8 96.69 185.04-214.84 0.55 103 131 179 88.55±0.50 
F4 3 3 8 96.21 184.5 - 214.5 0.56 36 144 42.6 95.34±0.64 
F5 3 3 8 97.16 184.26-214.12 0.53 151 59.6 311 83.06±0.42 
F6 3 3 8 95.98 185.06-215.06 0.71 70 86.3 217 95.98±0.67 
F7 3 3 8 96.21 184.82-214.78 0.54 74 110.8 91 90.71±0.66 
F8 3 3 8 96.45 184.7 -214.64 0.52 88 119.8 171 93.24±0.28 
F9 3 3 8 96.21 184.63-204.49 0.52 57 105.9 120 92.26±0.43 
F10 3 3 8 96.69 185 -214.98 0.66 100 110.3 150 93.06±0.29 
F11 3 3 8 95.74 184.76-214.72 0.65 74 129.6 72 90.21±0.24 
F12 3 3 8 96.45 184.92-214.9 0.66 30 108.7 87 92.41±0.15 
F13 3 3 8 95.74 184.88-214.86 0.48 25 107.5 29 93.37±0.18 
F14 3 3 8 96.21 184.85-214.81 0.50 24 126 21 96.24±0.15 
F15 3 3 8 96.69 184.88-214.86 0.70 19 129.6 4 97.19±0.28 
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Fig 1 Calibration of lamivudine 
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Fig 2 COMPARISON OF INVITRO RELEASE PROFILE OF LAMIVUDINE CONTAINING 
DIFFERENT PERCENTAGES OF CROSCARMALOSE SODIUM AS DISINTEGRAN 
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Fig 3 COMPARISON OF INVITRO RELEASE PROFILE OF LAMIVUDINE CONTAINING 
DIFFERENT PERCENTAGES OF SODIUM STARCH GLYCOLATE AS DISINTEGRANT 
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Fig 4 COMPARISON OF INVITRO RELEASE PROFILE OF LAMIVUDINE CONTAINING 
DIFFERENT PERCENTAGES OF CROSPOVIDONE AS DISINTEGRANT 
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DSC 
 
 
Fig – 5 DSC Thermogram of Lamivudine 
 
 
Fig – 6  DSC Thermogram of Croscarmallose sodium 
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Fig – 7 DSC Thermogram of  Sodium starch glycolate 
 
 
                    Fig – 8 DSC Thermogram of  Lamivudine + Sodium starch glycolate 
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                     Fig – 9 DSC Thermogram of Lamivudine+ Croscarmallose sodium 
 
 
              Fig – 10  DSC Thermogram of  Overlay of drug and various superdisintegrants 
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                                                                         FT- IR 
 
Fig- 11 FT-IR Spectrum of Lamivudine 
 
 
 
 
Fig- 12 FT-IR Spectrum of Sodium starch glycolate 
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                                Fig- 13  FT-IR Spectrum of Croscarmallose sodium 
 
                                Fig- 14 FT-IR Spectrum of Lamivudine + SSG 
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                          Fig- 15 FT-IR Spectrum of  lamivudine + CCS 
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CHAPTER-XI 
SUMMARY AND CONCLUSION 
 The purpose of the study was to formulate and evaluate Fast Dissolving Tablets of 
Lamivudine. 
 The results of Differential Scanning calorimetry(DSC) and Fourier Transmission 
Infra-Red spectroscopy confirm that both drug and excipients are compatible with 
each other and and are devoid of interactions. 
 The results of precompression studies like angle of repose, bulk density, tapped 
density, compressibility index and hausner’s ratio reveals that the prepared 
powder blends of all formulations possess good flow properties. 
 The tablets were prepared by direct compression method using superdisintegrants 
like Croscarmallose (F1 to F5), Sodium starch glycolate(F6 to F10), 
Crospovidone(F11 to F15) in different concentrations of 2%,4%,6%,8% and 
10%.Mannitol is used as both binder and sweetener, sodium saccharin for 
additional taste masking and Microcrystalline cellulose as diluent. The tablets 
obtained were of uniform shape and size. 
  The prepared tablets were subjected to post compression evaluations and the 
results indicate that    
 The hardness, thickness and diameters of all the tablets are uniform, which ensures 
that all the tablets were of uniform size and shape with good resistance against 
mechanical damage. 
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 The tablets of all formulations contains uniform amount of drug, which ensures 
content uniformity for tablets of all formulations. 
 The tablets were within the limits of weight variation test, which in turn indicate 
uniform distribution of contents of the powder blends of each formulations. 
 The friability of all the tablets was found to be ˂ 1%, which indicates the good 
mechanical resistance. 
 The tablets of all formulations were found to have minimum wetting time and 
maximum water absorption ratio which is the desired characteristic of fast dissolving 
tablets, which enables faster disintegration of tablets. 
 The disintegration time of all tablets were found to be less than three minutes, which 
ensures faster disintegration except for formulations (F1, F5 and F6). 
 The tablets of all the formulations were found to release more than 80% in 5 minutes, 
which is the desired quality of fast dissolving tablets that helps in faster absorption of 
the drug and quick onset of therapeutic effect except for formulations (F1 & F2). The 
dissolution pattern of various disintegrants used in the formulation was found to be in 
the order of Crospovidone ˃ Sodium starch glycolate ˃ Croscarmallose sodium. 
 
CONCLUSION 
It was concluded, that lamivudine can be successfully formulated as fast dissolving 
tablets using various superdisintegrants in different concentrations by direct compression 
method. The formulation containing 10% of crospovidone as superdisintegrant was found to 
be outstanding than other formulations in terms of disintegration time and rate of dissolution.                           
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